These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30416694)

  • 1. Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications.
    Kanbour I; Chandra P; Soliman A; De Sanctis V; Nashwan A; Abusamaan S; Moustafa A; Yassin MA
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018062. PubMed ID: 30416694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statural Growth and Prevalence of Endocrinopathies in Relation to Liver Iron Content (LIC) in Adult Patients with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD).
    Yassin MA; Soliman AT; De Sanctis V; Abdula MAJ; Riaz LM; Ghori FF; Yousaf A; Nashwan AJ; Abusamaan S; Moustafa A; Kohla S; Soliman DS
    Acta Biomed; 2018 Feb; 89(2-S):33-40. PubMed ID: 29451227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.
    Yassin MA; Soliman AT; De Sanctis V; Yassin KS; Abdulla MA
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019026. PubMed ID: 31205630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
    Soliman AT; Yassin MA; De Sanctis V
    Acta Biomed; 2018 Feb; 89(2-S):27-32. PubMed ID: 29451226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jadenu
    Yassin MA; Soliman AT; De Sanctis V; Hussein RM; Al-Okka R; Kassem N; Ghasoub R; Basha A; Nashwan AJ; Adel AM
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018064. PubMed ID: 30416696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Iron Overload in Patients with Acute Leukemia and Myelodysplastic Syndrome on Hepatic and Endocrine functions.
    Yassin MA; Soliman A; De Sanctis V; Hmissi SM; Abdulla MAJ; Ekeibed Y; Ismail O; Nashwan A; Soliman D; Almusharaf M; Hussein R
    Acta Biomed; 2018 Apr; 89(3-S):18-22. PubMed ID: 29633728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron burden and endocrine complications in transfusion-dependent thalassemia patients In Sarawak, Malaysia: a retrospective study.
    Chow LC; Lee BS; Tang SO; Loh EW; Ng SC; Tan XY; Ahmad Noordin MN; Ong GB; Chew LC
    Med J Malaysia; 2024 May; 79(3):281-287. PubMed ID: 38817060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Overload in Patients With Heavily Transfused Sickle Cell Disease-Correlation of Serum Ferritin With Cardiac T2
    Alkindi S; Panjwani V; Al-Rahbi S; Al-Saidi K; Pathare AV
    Front Med (Lausanne); 2021; 8():731102. PubMed ID: 34760898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Serum Ferritin and Liver Iron Concentration with Transient Liver Elastography in Adult Thalassemia Intermedia Patients with Blood Transfusion.
    Atmakusuma TD; Lubis AM
    J Blood Med; 2021; 12():235-243. PubMed ID: 33883962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients.
    El Beshlawy A; El Tagui M; Hamdy M; El Ghamrawy M; Azim KA; Salem D; Said F; Samir A; St Pierre T; Pennell DJ
    Ann Hematol; 2014 Mar; 93(3):375-9. PubMed ID: 23949317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of endocrine complications in transfusion dependent thalassemia in Hospital Pulau Pinang: A pilot study.
    Lee KT; Lim SL; Goh AS
    Med J Malaysia; 2020 Jan; 75(1):33-37. PubMed ID: 32008017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Iron Content (LIC) in Adults with Sickle Cell Disease (SCD): Correlation with Serum Ferritin and Liver Enzymes Concentrations in Trasfusion Dependent (TD-SCD) and Non-Transfusion Dependent (NT-SCD) Patients.
    Yassin M; Soliman A; De Sanctis V; Nashwan A; Abusamaan S; Moustafa A; Kohla S; Soliman D
    Mediterr J Hematol Infect Dis; 2017; 9(1):e2017037. PubMed ID: 28698780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.
    Carsote M; Vasiliu C; Trandafir AI; Albu SE; Dumitrascu MC; Popa A; Mehedintu C; Petca RC; Petca A; Sandru F
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai Thalassemia Centre.
    Belhoul KM; Bakir ML; Kadhim AM; Dewedar HE; Eldin MS; Alkhaja FA
    Ann Saudi Med; 2013; 33(1):18-21. PubMed ID: 23458935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR; De Sanctis V; Gilli G
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History of myocardial iron loading is a strong risk factor for diabetes mellitus and hypogonadism in adults with β thalassemia major.
    Ang AL; Tzoulis P; Prescott E; Davis BA; Barnard M; Shah FT
    Eur J Haematol; 2014 Mar; 92(3):229-36. PubMed ID: 24164584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between liver iron concentration determined by R2-MRI, serum ferritin, and liver enzymes in patients with thalassemia intermedia.
    Al-Momen H; Jasim SK; Hassan QA; Ali HH
    Blood Res; 2018 Dec; 53(4):314-319. PubMed ID: 30588469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major.
    Casale M; Marsella M; Ammirabile M; Spasiano A; Costantini S; Cinque P; Ricchi P; Filosa A
    Blood Transfus; 2019 May; 17(3):165-170. PubMed ID: 30036179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy.
    Porter JB; Elalfy MS; Taher AT; Aydinok Y; Chan LL; Lee SH; Sutcharitchan P; Habr D; Martin N; El-Beshlawy A
    Ann Hematol; 2013 Jan; 92(2):211-9. PubMed ID: 23086508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.